Internal Medicine, Interventional Cardiology · Fredericksburg, VA
NPI
1720079247
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
4604 Spotsylvania Pkwy Ste 200
Fredericksburg, VA, 22408
Phone (540) 361-2922
Groups this clinician bills Medicare through
Medicare paid, 2024
$757K
9,536 services
Medicare patients, 2024
1,442
Average age 76
Drug cost, 2024
$1.1M
7,107 prescriptions
Company payments, 2025
$776
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harish R Chandra was code 99214 (office e&m - established), 1,756 times for 887 patients. In total Harish R Chandra billed 9,536 services in 96 codes, and Medicare paid $757K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,756 | 887 | $87.17 | $153K |
| 93000 Electrocardiogram | Office | 1,025 | 718 | $10.12 | $10K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,000 | 246 | $5.24 | $5,236 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 696 | 343 | $84.23 | $59K |
| G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 685 | 20 | $99.05 | $68K |
| 93306 Echocardiography (TTE/TEE) | Office | 638 | 609 | $140.57 | $90K |
| 93010 Electrocardiogram | Facility | 387 | 336 | $5.97 | $2,311 |
| 93015 Electrocardiogram | Office | 348 | 343 | $43.81 | $15K |
| 78452 Myocardial Perfusion Scan | Office | 347 | 343 | $326.91 | $113K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 316 | 288 | $135.76 | $43K |
| 93294 External Electrocardiographic Monitoring | Office | 199 | 81 | $21.08 | $4,195 |
| 93297 External Electrocardiographic Monitoring | Office | 184 | 32 | $23.66 | $4,354 |
| 93298 External Electrocardiographic Monitoring | Office | 180 | 27 | $29.27 | $5,268 |
| 99213 Office E&M - Established | Office | 139 | 123 | $66.89 | $9,297 |
| 93296 External Electrocardiographic Monitoring | Office | 126 | 83 | $16.09 | $2,027 |
By year: 2022 $761K for 7,938 services; 2023 $876K for 10,808 services; 2024 $757K for 9,536 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harish R Chandra prescribed most often to Medicare patients was Metoprolol Succinate, with 663 prescriptions and refills. In total Harish R Chandra wrote 7,107 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 663 | 1,711 | 249 | $9,158 |
| Rosuvastatin Calcium Generic | 567 | 1,512 | 203 | $7,662 |
| Eliquis Apixaban | 560 | 971 | 158 | $530K |
| Carvedilol Generic | 502 | 1,213 | 165 | $3,983 |
| Furosemide Generic | 395 | 962 | 147 | $1,802 |
| Atorvastatin Calcium Generic | 370 | 997 | 125 | $3,494 |
| Clopidogrel Clopidogrel Bisulfate | 359 | 975 | 125 | $4,219 |
| Amlodipine Besylate Generic | 330 | 826 | 112 | $2,098 |
| Losartan Potassium Generic | 288 | 757 | 114 | $2,453 |
| Ezetimibe Generic | 239 | 606 | 74 | $6,460 |
| Lisinopril Generic | 189 | 521 | 71 | $1,362 |
| Spironolactone Generic | 138 | 349 | 51 | $1,164 |
| Entresto Sacubitril/Valsartan | 127 | 207 | 34 | $127K |
| Amiodarone Hcl Generic | 120 | 316 | 37 | $1,592 |
| Bisoprolol Fumarate Generic | 113 | 290 | 37 | $2,742 |
Brand drugs: - claims; generic drugs: 6,003 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harish R Chandra $776 ($776 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbott Laboratories with $197.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 3 | $197 |
| Baxter Healthcare BAX | 2 | $113 |
| Pfizer Inc. PFE | 5 | $104 |
| Novo Nordisk Inc NVO | 3 | $78.78 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $53.42 |
| Amgen Inc. AMGN | 3 | $48.62 |
| Medtronic, Inc. MDT | 2 | $39.77 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $26.01 |
| Scpharmaceuticals Inc. SCPH | 1 | $24.08 |
| Boston Scientific Corporation BSX | 1 | $23.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.